CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood T acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | classic Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Ewing sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute monocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
ASPACYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | esophageal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | esophageal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
CYTARABINE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | osteoporosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | central nervous system germ cell tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Digestive System Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nodular sclerosis Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia with maturation | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute graft vs. host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Waldenstrom macroglobulinemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | infiltrating bladder urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | ATC |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | uterine leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Juvenile Myelomonocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | mycosis fungoides | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Fanconi anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | adult T-cell leukemia/lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | refractory anemia with ringed sideroblasts | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | cervical squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Beta-thalassemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | uterine sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Central Nervous System Lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | uterine sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe combined immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | bone marrow failure syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | Cutaneous T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | lung neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ureter cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | classic Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe combined immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE HYDROCHLORIDE | Small molecule | ureter cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | post-transplant lymphoproliferative disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | Central Nervous System Lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | uterine leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | angioimmunoblastic T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | adult B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | spinal cord glioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | testicular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Thalassemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
TROXACITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Juvenile Myelomonocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | glioblastoma multiforme | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | plasma cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian mucinous cystadenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | medullary thyroid gland carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | osteosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | squamous cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | FDA |
GEMCITABINE HYDROCHLORIDE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic colorectal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | classic Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | ATC |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | T-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | central nervous system non-hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | squamous cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
TROXACITABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic scleroderma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Splenic Marginal Zone Lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Crohn's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple sclerosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | osteopetrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | nodal marginal zone B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cervical adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gastroesophageal junction adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | plasma cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | immune system disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | esophageal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | beta-thalassemia major | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | overactive bladder | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | mycosis fungoides | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | classic Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | malignant tumor of extrahepatic bile duct | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Sezary's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | mature T-cell and NK-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | T-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | rheumatoid arthritis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cervical carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | metastasis | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic scleroderma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | refractory anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hepatosplenic T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | endometrial cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | adult T-cell leukemia/lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | paroxysmal nocturnal hemoglobinuria | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Lymphoma, AIDS-Related | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse intrinsic pontine glioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-Cell Prolymphocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | gastrointestinal stromal tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leptomeningeal metastasis | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nodal marginal zone B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | T-cell large granular lymphocyte leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | glioblastoma multiforme | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | plasmacytoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | hilar cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CLOFARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Hereditary breast and ovarian cancer syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Crohn's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Vulvar Squamous Cell Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-cell non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic granulomatous disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute erythroleukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute monocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse intrinsic pontine glioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prolymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | cervical carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | refractory anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | childhood B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | skin cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | malignant epithelial tumor of ovary | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Myelodysplastic/Myeloproliferative Neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hairy cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | male breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute monocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | endometrioid carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | toxicity | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acquired aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | bone marrow failure syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoproliferative syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid system neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | malaria | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | uterine neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian serous cystadenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | aseptic meningitis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | mycosis fungoides | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute monocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | male breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute megakaryoblastic leukaemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | cervical adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | adult T-cell leukemia/lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | endometrial cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
FLUDARABINE PHOSPHATE | Small molecule | Wiskott-Aldrich syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | nodular sclerosis Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
TROXACITABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Hepatoblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Vulvar Squamous Cell Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | malignant colon neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature T-cells or NK-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | testicular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | post-transplant lymphoproliferative disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | refractory anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | overactive bladder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Thromboembolism | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | childhood T acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | uterine leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | bile duct cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | T-cell large granular lymphocyte leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Hereditary breast and ovarian cancer syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe congenital neutropenia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic scleroderma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | Central Nervous System Neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Shwachman-Diamond syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | psoriasis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | Myasthenia gravis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | angioimmunoblastic T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloblastic leukemia with maturation | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | hilar cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Thalassemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
ASPACYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | large cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | nodular sclerosis Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | epidermolysis bullosa | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | gliosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | core binding factor acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Fanconi anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lung adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | mycosis fungoides | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | brain cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | relapsing-remitting multiple sclerosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuromyelitis optica | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | skin cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | plasma cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Fanconi anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | testicular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic scleroderma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Ovarian Carcinosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic lupus erythematosus | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lupus nephritis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | endometrial adenosquamous carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | nodular sclerosis Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Richter syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Digestive System Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | mycosis fungoides | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Pure red cell aplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute basophilic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Sezary's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | infiltrating bladder urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | vasculitis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | T-Cell Prolymphocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian mucinous cystadenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | core binding factor acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | gastroesophageal junction adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Stiff-Person syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Uterine Carcinosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | adult B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Ewing sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | blastic plasmacytoid dendritic cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | endometrial adenosquamous carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | immune deficiency disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | refractory anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | meningeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urogenital neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | medulloblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | refractory anemia with excess blasts | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematologic disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Juvenile Myelomonocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Opsoclonus-Myoclonus Syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | precursor B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | post-transplant lymphoproliferative disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Kidney Medullary Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cervical carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | Thromboembolism | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroepithelial neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Terminated | ClinicalTrials |
TROXACITABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | hematologic disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Uveal Melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic/myeloproliferative disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | osteosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | synovial sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urogenital neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | overactive bladder | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | Endometrial Clear Cell Adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | skin cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic granulomatous disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Sezary's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prolymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | nodal marginal zone B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cervical carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | refractory anemia with excess blasts | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | bone marrow failure syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | systemic lupus erythematosus | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | chronic inflammatory demyelinating polyneuropathy | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastasis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney failure | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | adult T-cell leukemia/lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloblastic leukemia without maturation | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Diamond-Blackfan anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | nongerminomatous germ cell tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | Ovarian Carcinosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | combined hepatocellular carcinoma and cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | osteosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | toxicity | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Brain Stem Glioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Central Nervous System Neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | ATC |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | brain neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | congenital amegakaryocytic thrombocytopenia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | T-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | squamous cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Uterine Carcinosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | adult acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | refractory anemia with ringed sideroblasts | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematologic disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | aseptic meningitis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | MALT lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | medulloblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Malignant Pancreatic Neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lung neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Crohn's disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | adult B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | ependymal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prolymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myeloid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
CYTARABINE | Small molecule | acute megakaryoblastic leukaemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | childhood T acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | uterine leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloblastic leukemia without maturation | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | skin cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | classic Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | adult T acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nodal marginal zone B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | glioblastoma multiforme | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | endometrial cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urogenital neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | embryonal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | liver lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
FLUDARABINE PHOSPHATE | Small molecule | Waldenstrom macroglobulinemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Suspended | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | blastic plasmacytoid dendritic cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic colorectal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | mature T-cell and NK-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal type undifferentiated carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Fanconi anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cutaneous melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | esophageal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | paroxysmal nocturnal hemoglobinuria | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | thyroid cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | psoriatic arthritis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Juvenile Myelomonocytic Leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | central nervous system non-hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | liver cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | congenital amegakaryocytic thrombocytopenia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute graft vs. host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | anxiety | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | adult B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | T-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | cervical squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | malignant colon neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cervical carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nodular sclerosis Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Aplastic anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | neutropenia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | post-transplant lymphoproliferative disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | rectum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Richter syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | immune deficiency disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | Ewing sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bladder tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | anemia (phenotype) | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gastrointestinal disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | graft versus host disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | germ cell tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute megakaryoblastic leukaemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Wiskott-Aldrich syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | bone sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CLOFARABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Granulocytic Sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | osteopetrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | plasma cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
ASPACYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | polycythemia vera | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | head and neck malignant neoplasia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | colorectal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | osteosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | nasopharyngeal neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | triple-negative breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute erythroleukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | anaplastic large cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | androgenetic alopecia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
CLOFARABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | severe combined immunodeficiency | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelogenous leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | glioblastoma multiforme | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | epidermolysis bullosa | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Shwachman-Diamond syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | B-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | clear cell renal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | breast neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | hepatocellular carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute erythroleukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute leukemia of ambiguous lineage | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | childhood acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Lymphoma, AIDS-Related | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | gastrointestinal stromal tumor | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | malignant tumor of extrahepatic bile duct | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | central nervous system non-hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | systemic scleroderma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | myeloid sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | prostate cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute promyelocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Waldenstrom macroglobulinemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | breast carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | brain cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | peritoneum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | squamous cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Splenic Marginal Zone Lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | childhood acute myeloid leukemia with maturation | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Suspended | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelofibrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Hepatoblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | acute erythroblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
CYTARABINE | Small molecule | childhood B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | T-cell non-Hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic malignant neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neoplasm of mature B-cells | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
ASPACYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | multiple myeloma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | diffuse intrinsic pontine glioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | endometrioid carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | squamous cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute erythroblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ureter cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | osteopetrosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | renal pelvis/ureter urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | central nervous system cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Mantle cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | adult acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Parkinson disease | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | esophageal cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | squamous cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | chronic myeloproliferative disorder | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Kidney Medullary Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CLOFARABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | ATC |
GEMCITABINE | Small molecule | neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | polycythemia vera | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | gallbladder carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urethra cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | primary peritoneal carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | central nervous system non-hodgkin lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
CLOFARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | neuroblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | osteosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | Endometrial Clear Cell Adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | soft tissue sarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | malignant pleural mesothelioma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | bladder transitional cell carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | rectum cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | childhood B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | high grade B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-small cell lung carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian serous cystadenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | epidermolysis bullosa | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | chronic myelomonocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | fallopian tube cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | gastric cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | lymphoid neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 0.5 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | malignant epithelial tumor of ovary | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | neuromyelitis optica | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | urothelial carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
CYTARABINE | Small molecule | childhood B acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | intrahepatic cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | kidney cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | biliary tract cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lymphoproliferative syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Unknown status | ClinicalTrials |
CYTARABINE | Small molecule | mixed phenotype acute leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | myelodysplastic syndrome | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
CYTARABINE | Small molecule | acute lymphoblastic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | Burkitts lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | ovarian carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | medulloblastoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | plasmacytoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | Langerhans Cell Histiocytosis | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | thyroid cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | lung cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | T-lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | MALT lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
CYTARABINE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Enrolling by invitation | ClinicalTrials |
CYTARABINE | Small molecule | plasma cell leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | gastric cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
GEMCITABINE | Small molecule | combined hepatocellular carcinoma and cholangiocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Recruiting | ClinicalTrials |
CYTARABINE | Small molecule | T-lymphoblastic lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Beta-thalassemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
CYTARABINE | Small molecule | essential thrombocythemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | uterine neoplasm | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | anemia (phenotype) | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Terminated | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Central Nervous System Lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | Ocular Melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | uterine leiomyosarcoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | angioimmunoblastic T-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |
CLOFARABINE | Small molecule | cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | pancreatic ductal adenocarcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Terminated | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | pancreatic carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | Fallopian Tube Carcinoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
GEMCITABINE | Small molecule | urinary bladder cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | cervical cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | sickle cell anemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | chronic lymphocytic leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | - | DailyMed,FDA |
FLUDARABINE PHOSPHATE | Small molecule | diffuse large B-cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 3.0 | Completed | ClinicalTrials |
GEMCITABINE | Small molecule | non-Hodgkins lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
GEMCITABINE HYDROCHLORIDE | Small molecule | gastric cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | follicular lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Completed | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | acute myeloid leukemia | DNA polymerase (alpha/delta/epsilon) inhibitor | 4.0 | Unknown status | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | metastatic melanoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FLUDARABINE PHOSPHATE | Small molecule | breast cancer | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Terminated | ClinicalTrials |
GEMCITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA polymerase (alpha/delta/epsilon) inhibitor | 2.0 | Unknown status | ClinicalTrials |